EDGAR Filing Documents for 0001193125-18-115569

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-18-115569

Filing Date

2018-04-12

Accepted

2018-04-12 16:25:02

Documents

Effectiveness Date

2018-04-12

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d512518ddefa14a.htm	DEFA14A	40659
2	GRAPHIC	g51251844.jpg	GRAPHIC	2907
3	GRAPHIC	g51251845.jpg	GRAPHIC	2882
4	GRAPHIC	g512518logo1.jpg	GRAPHIC	8053
5	GRAPHIC	g512518logo2.jpg	GRAPHIC	2926
6	GRAPHIC	g512518logo3.jpg	GRAPHIC	2897
7	GRAPHIC	g512518naa02a.jpg	GRAPHIC	3663
	Complete submission text file	0001193125-18-115569.txt		74851

Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850

Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181

REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37553 | Film No.: 18752344
SIC: 2836 Biological Products, (No Diagnostic Substances)